The Care
Compass
Product review

Hims 3-in-1 Pill review

Hims 3-in-1 Pill: a pill dosage form with the same ingredient names as one Hard Mints formula, with formulation, cost, evidence and availability examined to identify who answers each question along the route to care.

Find a section in this guide

Knowing which product you are considering helps identify who should answer the next question. Hims 3-in-1 Pill describes a pill containing sildenafil, tadalafil and B12. Its ingredient questions belong with a clinician or pharmacist; its charges and shipments need their own confirmation. This review follows those responsibilities through the published offer.

Availability: Public product listing; individual eligibility and current prescription require confirmation.

All Hims product reviews

The exact product

At the first decision point, establish the exact prescription. The key issue is a pill dosage form with the same ingredient names as one Hard Mints formula. A platform's product list is not the same thing as a clinician's recommendation, and a chosen account plan is not dispensing confirmation. Ask the prescribing team to explain the ingredient choice and the pharmacy to clarify the supplied preparation. That division is especially useful when the public wording is broad or inconsistent.

The exact product: documented details
ProviderHims
Listed active ingredientsSildenafil + tadalafil + vitamin B12
Dosage formCompounded pill
Regulatory distinctionCompounded preparation; the finished product is not FDA-approved.
Source basisHims: 3-in-1 Pill formulation and safety · Hims: current ED treatment catalog

Price, supply and payment

The payment route begins with the public figure: From $35/month. Support should be able to connect the accepted quote to quantity, billing period and renewal. Ask whether assessment, medication and delivery are separate charges. If a pharmacy or prescription has not yet been assigned, a complete personal total may remain unavailable. Do not substitute a different product's price to finish the comparison prematurely.

Price, supply and payment: documented details
Catalog starting figureFrom $35/month
Formulation recordHims dedicated 3-in-1 Pill safety information
Important distinctionMatching ingredients do not establish matching strengths or absorption
ApprovalCompounded finished preparation; not FDA-approved

What the research can support

A marketing claim and its clinical interpretation can come from different people. The evidence relevant here is ingredient evidence; no equivalence study between the pill and chew verified; exact strengths and the selected billing commitment remains an open issue. Ask the clinician what evidence applies to the proposed preparation and why an alternative was not selected. A platform's description of speed, strength or convenience does not itself establish that reasoning for an individual patient.

What the research can support: documented details
Evidence boundaryingredient evidence; no equivalence study between the pill and chew verified
Not established hereexact strengths and the selected billing commitment
Clinical and regulatory referencesCui et al. (2015): daily tadalafil with as-needed sildenafil · MedlinePlus: Tadalafil · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Compounding and the FDA — questions and answers · MedlinePlus: Sildenafil

Safety questions for the prescriber

The clinical route needs the full medication history, including nitrates, recreational nitrites, riociguat, other ED drugs and blood-pressure treatment. Include relevant heart, kidney, liver and eye conditions. Do not ask an account or delivery representative to approve combining Hims 3-in-1 Pill with another medicine. The pharmacist can clarify label instructions, but uncertainty about suitability should return to the prescriber rather than being resolved by an online comparison.

Safety questions for the prescriber: documented details
Multiple PDE5 inhibitorsStandard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed.
Added nutrientsReview actual amounts and duplicate supplements; nutrient inclusion does not prove improved ED efficacy.

Availability and the actual prescription

The access finding is: Public product listing; individual eligibility and current prescription require confirmation. Ask which step determines state eligibility, product selection and pharmacy fulfillment. A page can describe an offer without establishing that each step is available for you. When a product is limited to existing enrollees, clarify that condition before changing an account. A later clinical decision can still change the available treatment even after an initial service eligibility check.

Refills, changes and cancellation

Plan the return route before treatment begins. Find the channel for unwanted effects or inadequate response, and separately identify the control for future charges. Use the product question “Why choose this pill instead of a single-ingredient tablet or the chew?” to start a focused clinical message. If a change is approved, confirm that the dispensing and account records both reflect it. A successful message send does not itself prove that a refill has been changed.

Refills, changes and cancellation: documented details
Next chargeThe next order date is the charge/processing date; a first refill can be scheduled early.
Cancellation noticeAt least 48 hours before the next order, according to support guidance.
Already processingEnding a subscription does not cancel an order already processing or shipped.
Refund boundaryNo refund guaranteed after pharmacy processing.
Policy sourcesHims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs

Compare named products

The linked options illustrate different product decisions within care pathways. Compare the formula and schedule first, then the practical route to assessment, dispensing and follow-up. More messaging features or faster shipping do not establish better clinical outcomes. A suitable alternative may require an examination or another service rather than a different selection in the same online catalog.

Questions to keep with the offer

This route map stops where public evidence stops. We have not followed a patient through enrollment, prescribing, shipment or cancellation for Hims 3-in-1 Pill. The references describe advertised terms and clinical context, not verified service performance. Use them to locate the right question and responsible professional before treating an online order as a complete care plan.

Questions to keep with the offer: documented details
Ask about this formulaWhy choose this pill instead of a single-ingredient tablet or the chew?
Ask about the paymentWhat are the exact quantity, total due now, renewal amount and notice deadline?
Ask about a changeWho confirms the medical instructions, pharmacy order and next account charge?

When to get urgent help

An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.

Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.

Back to all individual product reviews

Follow the sources

Checked October 7, 2026. Medical resources supply general context; provider pages describe advertised terms. A citation is not an endorsement of this publication or a service.

  1. Hims: 3-in-1 Pill formulation and safetyProvider formulation document; sildenafil, tadalafil and vitamin B12
  2. Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices
  3. Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing
  4. Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing
  5. Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals
  6. Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation
  7. Cui et al. (2015): daily tadalafil with as-needed sildenafilPrimary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI
  8. MedlinePlus: TadalafilDrug information; standard tadalafil products
  9. DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
  10. FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
  11. MedlinePlus: SildenafilDrug information; standard sildenafil products